Transfection is a process of introducing genetic material such as DNA or RNA into eukaryotic cells to enable the production or expression of proteins using the cell’s own machinery. A double stranded RNA transfection is employed to stop the production of certain proteins by hindering the translation process. The process of transfection enables the study of gene functioning and expression, genetic mutations, and protein functioning. Transfection can be divided into two types: stable and transient. Stable transfection is a process in which the transfected genetic material remains in the genome, during which a marker gene is co-transfected that gives selective advantage to the cell. In transient transfection, the induced gene is transiently expressed and hence is not incorporated into the nuclear genome, which is further diluted or degraded during the course of mitosis.
The transfection reagents and equipment market is driven by increased focus on the development of protein therapeutics, government initiatives to support health care, and increasing prevalence of diseases such as cancer and cardiovascular diseases. In addition, increase in mass production of proteins is projected to propel the market in the near future. Similarly, advances in cell research, target validation and drug discovery, and technological advances such as synthetic genes, whose demand has been growing, are anticipated to contribute to the growth of the market. Furthermore, a number of patent expiries during the forecast period are expected to fuel the growth of the biosimilars market. Development of biosimilars is highly dependent on the combination of genomic, proteomic, and cytological analysis, which would involve a significant application of transfection procedures. However, risk associated with the process of inserting genetic material into the cell, high cost of the transfecting reagents and equipment, selective effectiveness of transfecting reagents, the cytotoxic effects associated with the process, and the growing applications of home brew reagents are likely to hamper the growth of the market.
The transfection reagents and equipment market can be segmented based on product, application, end-user, and region. In terms of product, the market can be segmented into reagents and equipment. Reagents can be sub-segmented into lipid mediated transfection, DEAE-dextran, calcium phosphate, magnetic beads, activated dendrimers, and cationic polymers. Transfection equipment can sub-segmented into liposome mediated, electroporation, microinjection, laserfection, and adenoviral vectors, and others. The reagents segment is anticipated to record significant growth during the forecast period owing to the ease of the method and cost effectiveness. Based on application, the transfection reagents and equipment market can be segmented into gene expression, biomedical research, protein production, and others. In terms of end-user, the market can be segmented into research institutes, biotechnology companies, and others.
Geographically, the transfection reagents and equipment market can be segmented into five regions: North America, Europe, Latin America, Asia Pacific, and Middle East & Africa. North America is anticipated to be the high revenue generating region, closely followed by Europe. Rising demand for genomics technology and proteomics and increased government spending on health care in these regions contribute to the growth of the market. The market in Asia Pacific is anticipated to expand at a high CAGR during the forecast period. Increased outsourcing of clinical trials to countries in Asia, rise in demand for protein therapeutics, and developing health care infrastructure primarily in China and India fuel to the growth of the market. The transfection reagents and equipment market is in a nascent stage in countries in Middle East & Africa.
Leading players in the transfection reagents and equipment market include Thermo Fisher Scientific, Merck Millipore, QIAGEN N.V., Bio-Rad Laboratories, Promega Corporation, Lonza Group, F. Hoffmann-La Roche Ltd., Polyplus-transfection SA, Altogen Biosystems, and GE Healthcare.
This study by TMR is all-encompassing framework of the dynamics of the market. It mainly comprises critical assessment of consumers' or customers' journeys, current and emerging avenues, and strategic framework to enable CXOs take effective decisions.
Our key underpinning is the 4-Quadrant Framework EIRS that offers detailed visualization of four elements:
- Customer Experience Maps
- Insights and Tools based on data-driven research
- Actionable Results to meet all the business priorities
- Strategic Frameworks to boost the growth journey
The study strives to evaluate the current and future growth prospects, untapped avenues, factors shaping their revenue potential, and demand and consumption patterns in the global market by breaking it into region-wise assessment.
The following regional segments are covered comprehensively:
- North America
- Asia Pacific
- Latin America
- The Middle East and Africa
The EIRS quadrant framework in the report sums up our wide spectrum of data-driven research and advisory for CXOs to help them make better decisions for their businesses and stay as leaders.
Below is a snapshot of these quadrants.
1. Customer Experience Map
The study offers an in-depth assessment of various customers’ journeys pertinent to the market and its segments. It offers various customer impressions about the products and service use. The analysis takes a closer look at their pain points and fears across various customer touchpoints. The consultation and business intelligence solutions will help interested stakeholders, including CXOs, define customer experience maps tailored to their needs. This will help them aim at boosting customer engagement with their brands.
2. Insights and Tools
The various insights in the study are based on elaborate cycles of primary and secondary research the analysts engage with during the course of research. The analysts and expert advisors at TMR adopt industry-wide, quantitative customer insights tools and market projection methodologies to arrive at results, which makes them reliable. The study not just offers estimations and projections, but also an uncluttered evaluation of these figures on the market dynamics. These insights merge data-driven research framework with qualitative consultations for business owners, CXOs, policy makers, and investors. The insights will also help their customers overcome their fears.
3. Actionable Results
The findings presented in this study by TMR are an indispensable guide for meeting all business priorities, including mission-critical ones. The results when implemented have shown tangible benefits to business stakeholders and industry entities to boost their performance. The results are tailored to fit the individual strategic framework. The study also illustrates some of the recent case studies on solving various problems by companies they faced in their consolidation journey.
4. Strategic Frameworks
The study equips businesses and anyone interested in the market to frame broad strategic frameworks. This has become more important than ever, given the current uncertainty due to COVID-19. The study deliberates on consultations to overcome various such past disruptions and foresees new ones to boost the preparedness. The frameworks help businesses plan their strategic alignments for recovery from such disruptive trends. Further, analysts at TMR helps you break down the complex scenario and bring resiliency in uncertain times.
The report sheds light on various aspects and answers pertinent questions on the market. Some of the important ones are:
1. What can be the best investment choices for venturing into new product and service lines?
2. What value propositions should businesses aim at while making new research and development funding?
3. Which regulations will be most helpful for stakeholders to boost their supply chain network?
4. Which regions might see the demand maturing in certain segments in near future?
5. What are the some of the best cost optimization strategies with vendors that some well-entrenched players have gained success with?
6. Which are the key perspectives that the C-suite are leveraging to move businesses to new growth trajectory?
7. Which government regulations might challenge the status of key regional markets?
8. How will the emerging political and economic scenario affect opportunities in key growth areas?
9. What are some of the value-grab opportunities in various segments?
10. What will be the barrier to entry for new players in the market?
Note: Although care has been taken to maintain the highest levels of accuracy in TMR’s reports, recent market/vendor-specific changes may take time to reflect in the analysis.